Algernon Pharmaceuticals Inc files a pre-Investigational New Drug (IND) meeting request with US FDA for Phase 2 trial of Ifenprodil for chronic cough
It comes after the pharma group recently announced positive trending data from its Phase 2 study of the drug on idiopathic pulmonary fibrosis and...